Kristen Laguerre

Kristen Laguerre, an accomplished operating executive, is Managing Director, Chief Financial Officer and Chief Operating Officer at MPM BioImpact.
With over 20 years of financial leadership and management experience in the venture capital industry, her primary responsibility is to oversee the firm’s finance, operations and administrative functions.
Kristen is also an investment committee member of the Oncology Impact Funds, private/public funds focused on oncology as well as new modalities.
Kristen is currently serving as interim CFO at portfolio company ReNAgade Therapeutics and was previously CFO at portfolio company Cullinan Oncology (NASDAQ: CGEM).
Prior to joining MPM BioImpact, Kristen served as Partner and CFO at Flare Capital Partners, and, previously, Partner and CFO at Atlas Venture, an early-stage life sciences and technology venture capital firm, where she was responsible for finance, operations and administration.
Before Atlas Venture, she was Vice President – Finance at Softbank Capital, where she was responsible for finance, human resources and operations associated with both Softbank’s venture funds and its global activities outside of East Asia.
Earlier in her career, Kristen spent seven years at Arthur Andersen LLP.
Widely recognized in the private equity industry, Kristen is a board member of Financial Executives Alliance, a steering committee member of Women in Alternative Assets and previously served as a board member of the Private Equity CFO Association.
Kristen earned her M.B.A.
in Finance and Accounting from Boston University and her B.A.
in Economics from Wesleyan University.